CHI3L1 and Alzheimer disease: The first aim of this study was to assess the ability of glial (YKL-40, S100B, GFAP) and neurodegeneration (NFL) markers in CSF to discriminate between different CSF profiles (AD and non-AD) among subjects at the symptomatic pre- and early stages of dementia.